Ajinomoto, a Japanese food and biotechnology company, completed the acquisition of the remaining stake in Granules OmniChem, a manufacturer of pharmaceutical products, from Granules India, an Indian pharmaceutical manufacturing company. Financial terms were not disclosed. "The addition of Aji Bio-Pharma India is an integral extension of Aji Bio-Pharma's dedication to its customers to be a leading global and quality-driven CDMO with comprehensive service offerings. We are excited to officially welcome the Aji Bio-Pharma India team to our global family, and we look forward to providing a further streamlined experience for our clients as they continue to deepen their partnerships with us on essential programs in their product pipeline," David Enloe, Ajinomoto Bio-Pharma Services President and CEO.